Click here to close now.




















Welcome!

News Feed Item

India Orthobiologics Market Outlook to 2020

NEW YORK, March 11, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

India Orthobiologics Market Outlook to 2020
http://www.reportlinker.com/p02043354/India-Orthobiologics-Market-Outlook-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

India Orthobiologics Market Outlook to 2020

Summary

GlobalData's new report, "India Orthobiologics Market Outlook to 2020", provides key market data on the India Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the India Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc., Stryker Corporation and Alphatec Holdings, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Orthobiologics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Orthobiologics Market, India 7
3.1 Orthobiologics Market, India, Revenue ($m), 2005-2012 7
3.2 Orthobiologics Market, India, Revenue ($m), 2012-2020 9
3.2.1 Bone Graft Substitutes Market, India, Revenue ($m), by Segment, 2005-2012 11
3.2.2 Bone Graft Substitutes Market, India, Revenue ($m), by Segment, 2012-2020 13
3.3 Orthobiologics Market, India, Volume (Units), 2005-2012 15
3.4 Orthobiologics Market, India, Volume (Units), 2012-2020 17
3.4.1 Bone Graft Substitutes Market, India, Volume (Units), by Segment, 2005-2012 19
3.4.2 Bone Graft Substitutes Market, India, Volume (Units), by Segment, 2012-2020 21
3.5 Orthobiologics Market, India, Average Price ($), 2005-2020 23
3.6 Orthobiologics Market, India, Distribution Share by Revenue ($m), 2011-2012 25
3.7 Orthobiologics Market, India, Company Share by Revenue ($m), 2011-2012 26
4 Overview of Key Companies in India Orthobiologics Market 28
4.1 DePuy Companies 28
4.1.1 Company Overview 28
4.2 Sanofi 28
4.2.1 Company Overview 28
4.3 Baxter International Inc. 28
4.3.1 Company Overview 28
4.4 Medtronic, Inc. 29
4.4.1 Company Overview 29
4.5 Orthofix International N.V. 29
4.5.1 Company Overview 29
4.6 Biomet, Inc. 30
4.6.1 Company Overview 30
4.7 Smith & Nephew Plc 30
4.7.1 Company Overview 30
4.8 Wright Medical Group, Inc. 30
4.8.1 Company Overview 30
4.9 Stryker Corporation 31
4.9.1 Company Overview 31
5 Orthobiologics Market Pipeline Products 32
6 Financial Deals Landscape 34
6.1 Asset Transactions 34
6.1.1 Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 34
6.2 Partnerships 36
6.2.1 Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital 36
6.2.2 aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 37
7 Appendix 38
7.1 Research Methodology 39
7.1.1 Coverage 39
7.1.2 Secondary Research 39
7.1.3 Primary Research 40
7.1.4 Market Modeling and Forecasting 41
7.1.5 Company Share Analysis 44
7.1.6 Distribution Share Analysis 45
7.2 Expert Panel 46
7.3 GlobalData Consulting 46
7.4 Contact Us 46
7.5 Disclaimer 46

List of Tables

Table 1: Orthobiologics Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 8
Table 2: Orthobiologics Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 10
Table 3: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 12
Table 4: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 14
Table 5: Orthobiologics Market, India, Volume (Units), Historic, 2005-2012 16
Table 6: Orthobiologics Market, India, Volume (Units), Forecast, 2012-2020 18
Table 7: Bone Graft Substitutes Market, India, Volume (Units), Historic, 2005-2012 20
Table 8: Bone Graft Substitutes Market, India, Volume (Units), Forecast, 2012-2020 22
Table 9: Orthobiologics Market, India, Average Price ($), Historic, 2005-2012 23
Table 10: Orthobiologics Market, India, Average Price ($), Forecast, 2012-2020 24
Table 11: Orthobiologics Market, India, Distribution Share by Revenue ($m), USD Constant, 2011-2012 25
Table 12: Orthobiologics Market, India, Company Share by Revenue ($m), USD Constant, 2011-2012 27
Table 13: Orthobiologics Market Pipeline Products 32
Table 14: Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 34
Table 15: Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital 36
Table 16: aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 37
Table 17: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 41

List of Figures

Figure 1: Orthobiologics Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 7
Figure 2: Orthobiologics Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 9
Figure 3: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 11
Figure 4: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 13
Figure 5: Orthobiologics Market, India, Volume (Units), Historic, 2005-2012 15
Figure 6: Orthobiologics Market, India, Volume (Units), Forecast, 2012-2020 17
Figure 7: Bone Graft Substitutes Market, India, Volume (Units), Historic, 2005-2012 19
Figure 8: Bone Graft Substitutes Market, India, Volume (Units), Forecast, 2012-2020 21
Figure 9: Orthobiologics Market, India, Company Share (%), 2012 26
Figure 10: GlobalData Epidemiology-Based Forecasting Model 43
Figure 11: GlobalData Capital Equipment-Based Forecasting Model 44
Figure 12: Primary Interviews by Participant Type (%) 45

To order this report: India Orthobiologics Market Outlook to 2020
http://www.reportlinker.com/p02043354/India-Orthobiologics-Market-Outlook-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
With the proliferation of connected devices underpinning new Internet of Things systems, Brandon Schulz, Director of Luxoft IoT – Retail, will be looking at the transformation of the retail customer experience in brick and mortar stores in his session at @ThingsExpo. Questions he will address include: Will beacons drop to the wayside like QR codes, or be a proximity-based profit driver? How will the customer experience change in stores of all types when everything can be instrumented and a...
As more and more data is generated from a variety of connected devices, the need to get insights from this data and predict future behavior and trends is increasingly essential for businesses. Real-time stream processing is needed in a variety of different industries such as Manufacturing, Oil and Gas, Automobile, Finance, Online Retail, Smart Grids, and Healthcare. Azure Stream Analytics is a fully managed distributed stream computation service that provides low latency, scalable processing of ...
It’s been proven time and time again that in tech, diversity drives greater innovation, better team productivity and greater profits and market share. So what can we do in our DevOps teams to embrace diversity and help transform the culture of development and operations into a true “DevOps” team? In her session at DevOps Summit, Stefana Muller, Director, Product Management – Continuous Delivery at CA Technologies, answered that question citing examples, showing how to create opportunities for ...
Everyone talks about continuous integration and continuous delivery but those are just two ends of the pipeline. In the middle of DevOps is continuous testing (CT), and many organizations are struggling to implement continuous testing effectively. After all, without continuous testing there is no delivery. And Lab-As-A-Service (LaaS) enhances the CT with dynamic on-demand self-serve test topologies. CT together with LAAS make a powerful combination that perfectly serves complex software developm...
Skeuomorphism usually means retaining existing design cues in something new that doesn’t actually need them. However, the concept of skeuomorphism can be thought of as relating more broadly to applying existing patterns to new technologies that, in fact, cry out for new approaches. In his session at DevOps Summit, Gordon Haff, Senior Cloud Strategy Marketing and Evangelism Manager at Red Hat, discussed why containers should be paired with new architectural practices such as microservices rathe...
WebRTC has had a real tough three or four years, and so have those working with it. Only a few short years ago, the development world were excited about WebRTC and proclaiming how awesome it was. You might have played with the technology a couple of years ago, only to find the extra infrastructure requirements were painful to implement and poorly documented. This probably left a bitter taste in your mouth, especially when things went wrong.
Any Ops team trying to support a company in today’s cloud-connected world knows that a new way of thinking is required – one just as dramatic than the shift from Ops to DevOps. The diversity of modern operations requires teams to focus their impact on breadth vs. depth. In his session at DevOps Summit, Adam Serediuk, Director of Operations at xMatters, Inc., will discuss the strategic requirements of evolving from Ops to DevOps, and why modern Operations has begun leveraging the “NoOps” approa...
In today's digital world, change is the one constant. Disruptive innovations like cloud, mobility, social media, and the Internet of Things have reshaped the market and set new standards in customer expectations. To remain competitive, businesses must tap the potential of emerging technologies and markets through the rapid release of new products and services. However, the rigid and siloed structures of traditional IT platforms and processes are slowing them down – resulting in lengthy delivery ...
As more intelligent IoT applications shift into gear, they’re merging into the ever-increasing traffic flow of the Internet. It won’t be long before we experience bottlenecks, as IoT traffic peaks during rush hours. Organizations that are unprepared will find themselves by the side of the road unable to cross back into the fast lane. As billions of new devices begin to communicate and exchange data – will your infrastructure be scalable enough to handle this new interconnected world?
In their Live Hack” presentation at 17th Cloud Expo, Stephen Coty and Paul Fletcher, Chief Security Evangelists at Alert Logic, will provide the audience with a chance to see a live demonstration of the common tools cyber attackers use to attack cloud and traditional IT systems. This “Live Hack” uses open source attack tools that are free and available for download by anybody. Attendees will learn where to find and how to operate these tools for the purpose of testing their own IT infrastructu...
SYS-CON Events announced today that IceWarp will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. IceWarp, the leader of cloud and on-premise messaging, delivers secured email, chat, documents, conferencing and collaboration to today's mobile workforce, all in one unified interface
Too often with compelling new technologies market participants become overly enamored with that attractiveness of the technology and neglect underlying business drivers. This tendency, what some call the “newest shiny object syndrome,” is understandable given that virtually all of us are heavily engaged in technology. But it is also mistaken. Without concrete business cases driving its deployment, IoT, like many other technologies before it, will fade into obscurity.
Whether you like it or not, DevOps is on track for a remarkable alliance with security. The SEC didn’t approve the merger. And your boss hasn’t heard anything about it. Yet, this unruly triumvirate will soon dominate and deliver DevSecOps faster, cheaper, better, and on an unprecedented scale. In his session at DevOps Summit, Frank Bunger, VP of Customer Success at ScriptRock, will discuss how this cathartic moment will propel the DevOps movement from such stuff as dreams are made on to a prac...
Consumer IoT applications provide data about the user that just doesn’t exist in traditional PC or mobile web applications. This rich data, or “context,” enables the highly personalized consumer experiences that characterize many consumer IoT apps. This same data is also providing brands with unprecedented insight into how their connected products are being used, while, at the same time, powering highly targeted engagement and marketing opportunities. In his session at @ThingsExpo, Nathan Trel...
SYS-CON Events announced today that G2G3 will exhibit at SYS-CON's @DevOpsSummit Silicon Valley, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Based on a collective appreciation for user experience, design, and technology, G2G3 is uniquely qualified and motivated to redefine how organizations and people engage in an increasingly digital world.